TY - JOUR
T1 - Wall Teichoic Acid Mediates Staphylococcus aureus Binding to Endothelial Cells via the Scavenger Receptor LOX-1
AU - Slavetinsky, Jessica
AU - Lehmann, Esther
AU - Slavetinsky, Christoph
AU - Gritsch, Lisa
AU - van Dalen, Rob
AU - Kretschmer, Dorothee
AU - Bleul, Lisa
AU - Wolz, Christiane
AU - Weidenmaier, Christopher
AU - Peschel, Andreas
PY - 2023/11/10
Y1 - 2023/11/10
N2 - The success of Staphylococcus aureus as a major cause for endovascular infections depends on effective interactions with blood-vessel walls. We have previously shown that S. aureus uses its wall teichoic acid (WTA), a surface glycopolymer, to attach to endothelial cells. However, the endothelial WTA receptor remained unknown. We show here that the endothelial oxidized low-density lipoprotein receptor 1 (LOX-1) interacts with S. aureus WTA and permits effective binding of S. aureus to human endothelial cells. Purified LOX-1 bound to isolated S. aureus WTA. Ectopic LOX-1 expression led to increased binding of S. aureus wild type but not of a WTA-deficient mutant to a cell line, and LOX-1 blockage prevented S. aureus binding to endothelial cells. Moreover, WTA and LOX-1 expression levels correlated with the efficacy of the S. aureus-endothelial interaction. Thus, LOX-1 is an endothelial ligand for S. aureus, whose blockage may help to prevent or treat severe endovascular infections.
AB - The success of Staphylococcus aureus as a major cause for endovascular infections depends on effective interactions with blood-vessel walls. We have previously shown that S. aureus uses its wall teichoic acid (WTA), a surface glycopolymer, to attach to endothelial cells. However, the endothelial WTA receptor remained unknown. We show here that the endothelial oxidized low-density lipoprotein receptor 1 (LOX-1) interacts with S. aureus WTA and permits effective binding of S. aureus to human endothelial cells. Purified LOX-1 bound to isolated S. aureus WTA. Ectopic LOX-1 expression led to increased binding of S. aureus wild type but not of a WTA-deficient mutant to a cell line, and LOX-1 blockage prevented S. aureus binding to endothelial cells. Moreover, WTA and LOX-1 expression levels correlated with the efficacy of the S. aureus-endothelial interaction. Thus, LOX-1 is an endothelial ligand for S. aureus, whose blockage may help to prevent or treat severe endovascular infections.
KW - Humans
KW - Staphylococcus aureus/genetics
KW - Endothelial Cells
KW - Teichoic Acids/metabolism
KW - Receptors, Scavenger/metabolism
KW - Staphylococcal Infections
KW - Scavenger Receptors, Class E/genetics
U2 - 10.1021/acsinfecdis.3c00252
DO - 10.1021/acsinfecdis.3c00252
M3 - Article
C2 - 37910786
SN - 2373-8227
VL - 9
SP - 2133
EP - 2140
JO - ACS infectious diseases
JF - ACS infectious diseases
IS - 11
ER -